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Objectives: Few epidemiological studies have studied the effect of 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) on blood cytokine levels. In this study we investigated
changes in plasma levels of a large panel of cytokines, chemokines, and growth factors
among workers from a Dutch historical cohort occupationally exposed to chlorophenoxy
herbicides and contaminants including TCDD. Methods: Eighty-ﬁve workers who had
been exposed to either high (n = 47) or low (n = 38)TCDD levels more than 30 years before
serum collection were included in the current investigation. Plasma level of 16 cytokines,
10 chemokines, and 6 growth factors were measured. Current plasma levels of TCDD
(TCDDcurrent) were determined by high-resolution gas chromatography/isotope-dilution
high-resolution mass spectrometry. TCDD blood levels at the time of last exposure
(TCDDmax) were estimated using a one-compartment ﬁrst order kinetic model. Results:
Blood levels of most analytes had a negative association with current and estimated
past maximum TCDD levels. These decreases reached formal statistical signiﬁcance for
fractalkine, transforming growth factor alpha (TGF-α), and ﬁbroblast growth factor 2 (FGF2)
with increasing TCDD levels. Conclusion: Our study showed a general reduction in most
analyte levels with the strongest effects for fractalkine, FGF2, and TGF-α. These ﬁndings
suggest that TCDD exposure could suppress the immune system and that chemokine
and growth factor-dependent cellular pathway changes by TCDD may play role in TCDD
toxicity and associated health effects.
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INTRODUCTION
Immune suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) has been established in animal and experimental studies
(Marshall and Kerkvliet, 2010; Zhang et al., 2010). These stud-
ies showed that TCDD produces a wide range of toxic effects on
all components of the immune system including cytokines and
chemokines and might cause imbalance between T helper1 and T
helper2 cytokines (Fujimaki et al., 2002; Ito et al., 2002; Nohara
et al., 2002; Boverhof et al., 2004). However, few epidemiolog-
ical studies have evaluated TCDD effects on cytokine levels in
humans. These studies showed that TCDD exposure could reduce
serum IL4 levels (Oh et al., 2005) and INF-γ (Kim et al., 2003;
Oh et al., 2005) and/or increase IL4 and IL10 levels (Kim et al.,
2003). Another study found no changes in measured cytokine
levels (Neubert et al., 2000).
Exposure to chlorophenoxy herbicides or chlorophenols has
been shown to be associated with non-Hodgkin lymphoma
(NHL), in particular with TCDD exposure (Kogevinas et al.,
1997; Hardell et al., 1998; Bertazzi et al., 2001; Bodner et al.,
2003; Consonni et al., 2008). As the immune system has a
possible role in the development of lymphomas in particular
NHL (Dean et al., 1999; Pillemer, 2006; Rothman et al., 2006;
Dave, 2010; Gascoyne and Steidl, 2011; Purdue et al., 2011), the
possible link between NHL and TCDD might be governed by
TCDD-related perturbations (i.e., suppression) of the immune
system.
Cytokines play a pivotal role in immune function. Therefore,
blood levels of multiple cytokines collectively might appropri-
ately reﬂect subtle status of a deregulated immune response or
a failure to modulate the immune response due to TCDD expo-
sure. Previous studies investigating the effects of TCDD exposure
on blood cytokine levels only studied a few selected cytokines
and results showed considerable discrepancies. Here, we set out
to investigate the association between exposure to TCDD and
plasma concentration of a large panel of cytokines, chemokines,
and growth factors in subjects historically exposed toTCDD. Study
subjects comprised a subset of a retrospective cohort of Dutch
workers, part of the IARC multinational study of workers exposed
to chlorophenoxy herbicides, chlorophenols, and dioxins during
their working life (Bueno de Mesquita et al., 1993; Kogevinas et al.,
1997;Hooiveld et al., 1998; Boers et al., 2010; SaberiHosnijeh et al.,
2011).
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MATERIALS AND METHODS
STUDY POPULATION
The cohort study design and exposure assessment have been previ-
ously described in detail (Bueno de Mesquita et al., 1993; Hooiveld
et al., 1998; Boers et al., 2010). Brieﬂy, the cohort consists of
workers from two chlorophenoxy herbicide producing factories.
Current analyses utilized a subset of workers from one factory
(labeled “A” in previous publications) who were exposed to TCDD
as a byproduct of the production of 2,4,5-trichlorophenoxyacetic
acid and 2,4,5-trichlorophenol during 1953–1969, and/or during
an uncontrolled reaction in 1963. High-exposed workers were
selected for blood collection if (1) they were still alive at the end
of follow-up (December 31st, 2006); (2) they had been exposed
due to the industrial accident (both factory workers and con-
tract workers hired to clean-up after the accident; n = 29); or if
(3) they worked in departments of main production (n = 21).
High-exposed workers were matched to 43 low-exposed work-
ers employed in non-production departments by factory, sex, age
(within 5 years), and current residence (at ﬁrst two digits of postal
code). All study subjects were male. The study was conducted with
the approval of the Medical Ethics Committee of the University
Medical Center Utrecht, the Netherlands and written informed
consent was obtained from each study subject after the study was
explained. Participants were asked to complete a self-administered
questionnaire, which included questions on occupational history,
personal medical history, medication used in the weeks before the
study, anthropometric characteristics, smoking status, and alco-
hol intake. Blood plasma samples were collected according to
a standard protocol during home visits between May 2007 and
September 2008 (Boers et al., 2012; Saberi Hosnijeh et al., 2011).
CYTOKINES MEASUREMENTS
Blood samples were generally collected in the afternoon, but
occasionally also early morning or in the evening. Samples were
processed within 1 h of being collected and stored on ice at
0˚C, and were transported to the lab where they subsequently
were stored at −80˚C. Heparinized plasma samples were ana-
lyzed for a large panel of cytokines, chemokines, and growth
factors including interleukin (IL)1β, IL2, IL4, IL5, IL6, IL7, IL8,
IL10, IL12, IL13, interferon alpha (INF-α), interferon gamma
(INF-γ), tumor necrosis factor alpha (TNF-α), eotaxin, IL1
receptor antagonist (IL1ra), interferon gamma-induced protein
10 (IP10), granulocyte–macrophage colony-stimulating factor
(GMCSF), epidermal growth factor (EGF), ﬁbroblast growth fac-
tor 2 (FGF2), fms-like tyrosine kinase receptor-3 (Flt3) ligand pro-
tein (Flt3 ligand), granulocyte colony-stimulating factor (GCSF),
melanoma growth stimulatory activity/growth-related oncogene
(GRO), monocyte chemotactic protein-1 (MCP-1), monocyte
chemotactic protein-3 (MCP-3), macrophage derived chemokine
(MDC), macrophage inﬂammatory protein-1 alpha (MIP-1α),
macrophage inﬂammatory protein-1 beta (MIP-1β), solubleCD40
ligand (sCD40L), soluble IL2 receptor alpha (sIL2Rα), trans-
forming growth factor alpha (TGF-α), and vascular endothelial
growth factor (VEGF) using the milliplex HCYTOMAG-60SK and
HSCYTMAG-60SK kits, according to the protocol described by
the manufacturer. Blood samples of high and low-exposed work-
ers were randomly analyzed on two plates. A subset of samples
(15 high-exposed and 14 low-exposed) were analyzed in dupli-
cate. The median coefﬁcient of variation for all analytes measured
in duplicate was 11.9% (0.69–79.8). Intra class of correlation
coefﬁcients (ICCs) varied from 0.31 to 0.98 with a median of
0.72. The lower limits of detection (LOD) were 0.04 pg/mL for
IL5, 0.05 pg/mL for IL8, 0.06 pg/mL for IL1β, 0.07 pg/mL for
TNF-α, 0.15 pg/mL for GMCSF, 0.18 pg/mL for IL13 and INF-
γ, 0.20 pg/mL for IL6 and IL7, 0.26 pg/mL for IL2, 0.34 pg/mL
for IL12, 0.42 pg/mL for IL4, 0.48 pg/mL for IL10, 0.8 pg/mL for
TGF-α, 1.8 pg/mL for GCSF, 1.9 pg/mL for MCP-1, 2.8 pg/mL for
EGF, 2.9 pg/mL for MIP-1a and INF-α, 3.0 pg/mL for MIP-1b,
3.6 pg/mL for MDC, 3.8 pg/mL for MCP-3, 4.0 pg/mL for eotaxin,
5.1 pg/mL for sCD40L, 5.4 pg/mL for Flt3 ligand, 7.6 pg/mL for
FGF2,8.3 pg/mL for IL1ra, 8.6 pg/mL for IP10,9.9 pg/mL forGRO,
11.2 pg/mL for sIL2Ra, 22.7 pg/mL for fractalkine, 26.3 pg/mL for
VEGF.
EXPOSURE MEASUREMENTS
Heparin plasma samples of all subjects were analyzed for TCDD,
at the Centers for Diseases Control and Prevention (CDC;Atlanta,
USA) using high-resolution gas chromatography/isotope-dilution
high-resolution mass spectrometry. Results were lipid adjusted
and reported as parts per trillion (ppt) (Patterson et al., 1991).
EXPOSURE METRICS
TCDD is highly persistentwith a long half-life in blood andhuman
tissues. As we measured current levels of TCDD (TCDDcurrent)
approximately 35 years since last occupational exposure, a one-
compartment ﬁrst order kineticmodelwith aTCDDhalf-life (t 1/2)
of 7.1 years was used to estimate TCDD blood levels at the time of
last occupational exposure (TCDDmax) (Boers et al., 2010, 2012;
Saberi Hosnijeh et al., 2011):
TCDDmax = backround +
(
measured TCDD − background)∗
exp
(
ln (2)∗ tag/t1/2
)
Current TCDD levels and estimated maximum TCDD levels
were subsequently used to investigate exposure–response relations
between TCDD levels and analytes measured.
STATISTICAL ANALYSIS
Individual TCDD levels and analyte concentrations which were
below the LOD were imputed via a maximum likelihood esti-
mation method (Lubin et al., 2004). This procedure generates
unbiased statistics when at least 50% of measurements are above
the limit of detection (Lubin et al., 2004). Therefore, no sum-
mary statistics were calculated for cytokines with more than 50%
of measures below the LOD (IL1β, IL2, IL12, IL13, INF-γ, Flt3
ligand, INF-α, IL1ra, MCP-3, sIL2Ra, and VEGF). TCDD levels
and analytes concentrations were natural log (ln)-transformed as
measured levels appeared to follow a log-normal distribution.
Differences in continuous and categorical parameters between
exposed and low-exposed subjects were tested using a two sample
t -test and chi-square test, respectively.
We modeled exposure–response relations between ln-
transformed analyte concentrations as the dependent variable
and ln-transformed TCDDcurrent or TCDDmax as the independent
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variable using linear regression analyses. Models were adjusted for
potential confounders including body mass index (in kg/m2; con-
tinuous variable); alcohol intake (unit/week; continuous variable),
smoking (categorical variable; current, former, never), medica-
tion (yes/no; immunosuppressant, antibiotics, anti-inﬂammatory
drugs), and chronic and acutemedical conditions (present/absent)
and laboratory testing day/batch (day 1, 2). As more than 50% of
high and low-exposed workers had a chronic disease, exposure–
response relations were also investigated in subjects free of chronic
disease as a sensitivity analysis. A second sensitivity analyses was
performed among workers who did not use any immunosuppres-
sant drugs. Finally, we corrected the associations for blood cell
counts (major cell types including white blood cells, lymphocytes,
B cells, and monocytes; Saberi Hosnijeh et al., submitted) in order
to remove the possibility that effects in analyte concentrationswere
driven by a reduction in absolute cell counts.
Statistical analyses were performed using SAS (ver. 9.2; SAS
Institute Inc., Cary, NC, USA). All p-values were two-sided, with
p < 0.05 considered statistically signiﬁcant.
RESULTS
CHARACTERISTICS OF PARTICIPANTS
Two subjects with missing TCDD results as well as six subjects
with a previous cancer (non-skin) diagnosis (two high-exposed
and four low-exposed workers) were removed from the analy-
ses. The latter exclusion was made to remove the possibility that
analytes levelsmay have been changed in subjects due tomalignant
disease or treatment. Therefore, a total of 85 subjects (47 high-
exposed workers and 38 low-exposed workers) were available for
analysis. Exclusion of study subjects did not result in a distortion
of the frequency matching status. Plasma cytokines, chemokines,
and growth factors concentrations were successfully measured in
all workers.
Subject characteristics (n = 85) are shown in Table 1. Low-
exposed workers had higher alcohol intake compared to high-
exposed workers (p = 0.05). Smoking status among high and low-
exposed workers was similar. Although the distribution of chronic
diseases, chronic inﬂammatory diseases, and infection were sim-
ilar among high and low-exposed workers, more than 50% of
high and low-exposed workers suffered from chronic diseases such
as diabetes, cardiovascular diseases, and hypertension. Geomet-
ric mean (GM) and geometric SD (GSD) levels of TCDDcurrent
and historical maximum exposure (TCDDmax) were signiﬁcantly
higher in high-exposed workers (TCDDcurrent: 3.25± 7.43 ppt;
TCDDmax: 79.82± 33.28 ppt) compared to low-exposed work-
ers (TCDDcurrent: 1.07± 6.42 ppt; TCDDmax: 7.53± 32.14 ppt).
However, TCDD exposure levels between high- and low-exposed
workers largely overlapped (data not shown).
CYTOKINE CONCENTRATIONS
Table 2 shows cytokine, chemokine, and growth factor levels for
high and low-exposed workers. Blood levels of most analytes were
lower in high-exposed workers as compared to low-exposed work-
ers. This reduction varied from 1% for MDC to 67% for GMCSF
Table 1 | General characteristics of high and lowTCDD exposed workers.
High-exposed (n=47) Low-exposed (n=38) p-Value£
Age (years)* 69.07 (7.45) 68.55 (7.93) 0.75
Body mass index (kg/m2)* 27.33 (3.10) 26.65 (3.04) 0.31
Alcohol intake (units/week)* 11.48 (13.56) 17.26 (13.16) 0.05
Smoking status, N (%) 0.84
Current smoker 12 (25.5) 8 (21.1)
Former smoker 28 (59.6) 23 (60.5)
Never smoker 7 (14.9) 7 (18.4)
Skin cancer, N (%) 4 (8.5) 3 (7.9) 0.92
Infectious disease in the past 4weeks, N (%) 4 (8.7) 4 (10.5) 0.78
Chronic disease, N (%)† 24 (51.1) 20 (52.6) 0.89
Chronic inﬂammatory disease, N (%)‡ 13 (27.7) 11 (28.9) 0.90
Medication, N (%) 0.33
Immunosuppressant 5 (10.6) 4 (10.5)
NSAIDs 14 (29.8) 6 (15.8)
Antibiotics 0 1 (2.6)
TCDDcurrent (ppt)ª 3.25 (7.43) 1.07 (6.42) 0.002
TCDDmax (ppt)b 79.82 (33.28) 7.53 (32.14) 0.001
*Mean (SD); NSAIDs, non-steroidal anti-inﬂammatory drugs.
†Chronic diseases included: diabetes, coronary heart disease, and hypertension.
‡Chronic inﬂammatory diseases: chronic obstructive pulmonary disease, psoriasis, sarcoidosis, asthmatic bronchitis, rheumatoid arthritis, liver failure, Crohn’s disease,
ﬁbromyalgia, and allergy.
ªCurrent levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDDcurrent) parts per trillion, geometric mean (geometric SD).
bEstimated maximum levels of TCDD (TCDDmax) parts per trillion, geometric mean (geometric SD).
£p-values from t-tests for continuous variables and χ2 tests for categorical variables.
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Table 2 | Plasma cytokines concentrations among high and lowTCDD exposed workers (n =85).
Out of 114ª measurement, n<LOD High-exposed (n=47) Low-exposed (n=38) p-Value*
GM GSD GM GSD
IL4 40 0.84 6.68 1.63 7.06 0.12
IL5 21 0.19 5.21 0.37 3.78 0.05
IL6 6 2.38 3.19 3.13 4.66 0.35
IL7 17 0.41 2.61 0.58 3.94 0.16
IL8 0 3.71 1.75 3.39 2.18 0.58
IL10 9 4.39 3.86 4.35 3.78 0.97
GMCSF 24 0.32 8.08 0.97 11.47 0.03
TNF-α 2 5.37 2.61 5.70 2.44 0.77
EGF 19 16.12 5.37 25.53 6.05 0.24
Eotaxin 1 340.36 2.53 395.44 2.16 0.41
FGF2 47 8.1 4.69 8.67 6.23 0.88
Fractalkine 56 14.01 4.10 19.89 3.29 0.23
GCSF 9 12.68 3.97 17.64 2.5 0.22
GRO 4 333.62 3.35 391.51 2.59 0.51
IP10 4 445.86 3.29 411.58 2.92 0.75
MCP-1 3 262.43 3.78 239.85 4.39 0.77
MDC 0 772.78 1.68 780.55 1.80 0.95
MIP-1α 43 2.72 4.39 0.38 4.95 0.91
MIP-1b 19 14.73 4.53 20.91 4.44 0.28
sCD40L 2 854.06 3.82 1312.91 2.64 0.10
TGF-α 29 0.65 4.57 1.04 5.75 0.19
GM, geometric mean; GSD, geometric SD; IL, interleukin; GMCSF, granulocyte–macrophage colony-stimulating factor; TNF-α, tumor necrosis factor alpha; EGF,
epidermal growth factor; FGF2, ﬁbroblast growth factor 2; GCSF, granulocyte colony-stimulating factor; GRO, melanoma growth stimulatory activity/growth-related
oncogene; IP10, interferon gamma-induced protein 10; MCP-1, monocyte chemotactic protein-1; MDC, macrophage derived chemokine; MIP-1α, macrophage inﬂam-
matory protein-1 alpha MIP-1b, macrophage inﬂammatory protein-1 beta; sCD40L, soluble CD40 ligand; TGF-α, transforming growth factor alpha; *p-values are from
t-tests of natural log-transformed values; ª all measurements including duplicates.
(mean= 28.5%). A signiﬁcant decrease in IL5 and GMCSF levels
was found among high and low-exposed workers.
DOSE–RESPONSE ANALYSES
Linear regression analysis showed that most of measured ana-
lytes had a negative, although non-signiﬁcant, association with
TCDDcurrent levels (Table 3). We found a signiﬁcant linear asso-
ciation for FGF2, fractalkine, and TGF-α with TCDDcurrent levels
in both univariate and multivariate analyses. Sensitivity analysis
restricted to chronic disease-free subjects and to subjects using
no immunosuppressant drugs showed similar results except that
TGF-α andFGF2becamenon-signiﬁcant because of limitedpower
(data not shown). When we corrected observed multivariate asso-
ciations for major blood cell counts (Saberi Hosnijeh et al., sub-
mitted), fractalkine, and TGF-α remained signiﬁcantly associated.
Subsequently, regression analyses were done for high and low-
exposed subjects separately. Although these analyses showed neg-
ative trends for fractalkine, FGF2, and TGF-α with current TCDD
levels among both high and low-exposed workers (Figure 1), the
associationswere statistically signiﬁcant only amonghigh-exposed
workers. Regression analyses with estimated maximum TCDD
levels at time of last exposure (TCDDmax) rendered essentially
similar results albeit associations were slightly weaker (data not
shown).
DISCUSSIONS
The present paper reports on associations between past occu-
pational exposure to high levels of TCDD and plasma levels of
several cytokines, chemokines, and growth factors in a periph-
eral blood sample of workers exposed to the high levels of TCDD
approximately 35 years prior to blood collection. We found a non-
signiﬁcant reduction in plasma levels of most measured analytes
with increasing levels of TCDD. However only fractalkine, TGF-α,
and FGF2 showed a statistically signiﬁcant association with TCDD
levels.Our study is the ﬁrst study to evaluate plasma levels of a large
panel of cytokines in relation to TCDD exposure in humans.
Our results showed an overall decrease in plasma levels of most
cytokines, chemokines, and growth factors with increasing TCDD
levels. There is limited evidence in the literature on plasma levels of
cytokines in relation to TCDD exposure, probably because popu-
lations exposed exclusively or primarily to TCDDare rare. Oh et al.
(2005) measured serum IL4 and INF-γ among waste incineration
workers and showed a reduction in both cytokines in the exposed
workers (n = 31) compared to the matched, unexposed healthy
control group (n = 84) which was statistically signiﬁcant for IL4
(p = 0.004). In this study the level of dioxin exposurewas evaluated
by measuring the aerial dioxin concentrations in the working area
of the company that was 100 times higher than that of the con-
trol population. In a study among company workers involved in
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Table 3 | Dose–effect relationships between ln-transformed cytokines measurements and ln-transformedTCDDcurrent concentrations.
Univariate, N =85 Multivariate*, N =85
Estimate 95% CI Estimate 95% CI
IL4 −0.150 −0.358 to 0.059 −0.222 −0.455 to 0.111
IL5 −0.044 −0.211 to 0.123 −0.061 −0.232 to 0.110
IL6 −0.094 −0.238 to 0.051 −0.148 −0.312 to 0.017
IL7 −0.022 −0.149 to 0.105 −0.046 −0.197 to 0.105
IL8 0.010 −0.062 to 0.082 −0.006 −0.088 to 0.076
IL10 −0.051 −0.196 to 0.093 −0.056 −0.218 to 0.107
GMCSF −0.102 −0.351 to 0.147 −0.258 −0.539 to 0.023
TNF-α 0.020 −0.080 to 0.121 0.030 −0.136 to 0.077
EGF 0.010 −0.179 to 0.200 0.044 −0.166 to 0.254
Eotaxin 0.002 −0.092 to 0.096 0.017 −0.090 to 0.124
FGF2 −0.184 −0.361 to −0.008 −0.180 −0.364 to 0.003
Fractalkine −0.197 −0.333 to −0.060 −0.216 −0.368 to −0.064
GCSF 0.012 −0.122 to 0.146 −0.067 −0.199 to 0.066
GRO −0.011 −0.130 to 0.108 −0.0001 −0.120 to 0.120
IP10 0.091 −0.030 to 0.212 0.063 −0.067 to 0.193
MCP-1 0.107 −0.042 to 0.256 0.127 −0.037 to 0.290
MDC 0.004 −0.055 to 0.064 0.024 −0.044 to 0.093
MIP-1a −0.102 −0.266 to 0.062 −0.051 −0.216 to 0.115
MIP-1b −0.154 −0.315 to 0.005 −0.146 −0.304 to 0.012
sCD40L −0.012 −0.142 to 0.119 −0.008 −0.144 to 0.129
TGF-α −0.222 −0.392 to −0.051 −0.249 −0.431 to −0.067
*Covariates included in themultivariate models were age, bodymass index, alcohol intake, smoking, chronic disease, chronic inﬂammatory disease, infectious disease
within 4weeks before blood sampling, medication, and test day/batch.
decontamination work, Neubert et al. (2000) reported no changes
in plasma levels of IL1α, IL1β, IL6, and TNF-α among TCDD
exposed subjects (n = 12, TCDD level= 23–140 ppt) compared
to low-exposed (n = 33, TCDD level= 1–3 ppt) and medium
exposed subjects (n = 28, TCDD level= 4–9 ppt) despite a general
reduction in the median plasma levels of most measured analytes
among the high-exposed group. Similar to these studies on blood
cytokines we found a decrease in most analytes among which IL4,
IL6, andTNF-α, albeit non-signiﬁcant. Immune suppression char-
acterized by suppressed humoral and cell-mediated immunity is
a well-known toxic endpoint of TCDD exposure in animal and
experimental studies (Marshall and Kerkvliet, 2010). It is accepted
that the toxic effects of TCDD generally are mediated through the
aryl hydrocarbon receptor (AhR) signaling pathway (Marshall and
Kerkvliet, 2010). However, the mechanistic pathways are unclear
in humans. In a study on the relation between immune blood
cells and TCDD levels among the same study population as pre-
sented here (SaberiHosnijeh et al., submitted),we found an overall
reduction in most blood cell counts in particular B lymphocyte
cells. When we corrected the observed associations of the present
study for white blood cells, monocytes, lymphocytes, and B lym-
phocyte cell counts results did not change for fractalkine, TGF-α
and FGF2, and the other analytes with the exception of IL4, IL6,
and GMCSF for which the association with TCDD became bor-
derline statistically signiﬁcant. Therefore, it seems that the general
suppression observed for the measured analytes are independent
of the observed reduction in cell counts among exposed subjects
and that TCDD exposure in humans might therefore inﬂuence on
both function and the number of immune cells.
We found a signiﬁcant negative association between plasma
levels of fractalkine and TCDD levels. Fractalkine is an atyp-
ical chemokine existing as membrane-bound and in soluble
form. The soluble form of fractalkine is chemotactic to cyto-
toxic T cells and monocytes and natural killer cells (Imai et al.,
1997; Raychaudhuri et al., 2001). It is likely that fractalkine
might induce an antitumor immune response by recruiting
these cells into tumor tissues and stimulating their adhesion
to tumor cells. Moreover, the results of a study by Shiraishi et
al. showed that the fractalkine gene is a direct target of the
tumor suppressor p53. They have suggested that p53 may elim-
inate aberrant/damaged cells by the host immune response sys-
tem through transcriptional regulation of fractalkine (Shiraishi
et al., 2000). However, to date, there is no published literature
on fractalkine levels in relation to TCDD exposure. Our ﬁnding
for fractalkine is interesting as it has been shown that a decrease
in fractalkine receptor (CX3CR1) expression might play a role in
immune responses against adult T cell lymphoma (Shimizu et al.,
2007).
Cell growth and differentiation are regulated by numerous
growth factors and cytokines. There is growing animal and in vitro
evidence that TCDD inﬂuences growth factor-dependent cellular
pathways (Haarmann-Stemmann et al., 2009). It has been shown
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FIGURE 1 | Linear regression between ln-transformedTCDD levels and
ln-transformed analytes (i.e., FGF2, Fractalkine, andTGF-α) adjusted for
age, body mass index, alcohol intake, smoking, chronic disease, chronic
inflammatory disease, infectious disease within 4weeks before blood
sampling, medication, and test day/batch; solid line indicates
high-exposed subjects and dashed line, low-exposed subjects on the rug
plot. A group mean centering parameterization (group’s mean is subtracted
from the corresponding individual values) for the models was used to have
equivalent models with identical deviance and residual errors; TCDD exposure
levels between high- and low-exposed workers largely overlap.
that inhibited expression of some growth factors including EGF,
TGF-α, and TGF-β levels are main inﬂuencing factors during
TCDD-induced developmental effects in animals (Abbott et al.,
2003;Puga et al., 2005).A recent animal studyonprostatic budding
impairment after TCDD exposure suggested that TCDD likely acts
through downstream of FGFR2 and extracellular signal–regulated
kinase (Vezina et al., 2010). In vitro human studies showed that
TCDD exposure induced post-transcriptional TGF-α expression
in culture of human keratinocyte cell line (Choi et al., 1991; Gaido
et al., 1992). Although TGF-α is expressed by epithelial cells, ker-
atinocytes, and macrophages (Rappolee et al., 1988; Humphreys
and Hennighausen, 2000), it is not clear whether other cell types
can also produce TGF-α in response to TCDD exposure. Although
we observed a statistical signiﬁcant decrease in plasma levels of
TGF-α and FGF2, the clinical signiﬁcance of the results is not
clear.
There are some limitations to our study including limited sam-
ple size, possible bias due to selective survival, andmultiple testing.
Moreover, residual confounding by smoking (no information on
intensity and duration of smoking) is unlikely as smoking in gen-
eral did not change the results.We had only a cross-sectional blood
sampling that limited us in obtaining more insight into acute vs.
long-term changes in cytokines, chemokines, and growth factors
levels. Finally, as in our study TCDDmax and TCDDcurrent are
highly correlated (Pearson correlation coefﬁcient 0.97,p < 0.01), it
was difﬁcult to differentiate between effects thatmight be related to
high levels of exposure in the past (TCDDmax) and effects related
to current TCDD levels.
In conclusions, our results showed that plasma levels of TCDD
were associated with an overall decrease in blood levels of most
cytokines, chemokines, and growth factors which were statistically
signiﬁcant for fractalkine, FGF2, and TGF-α. These results pro-
vide evidence of immunological effects of TCDD in humans and
provide additional support for lymphomagenesis of TCDD.
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